SWX:ROG.SW

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

As of December 20, 2025, healthcare stocks are heading into year-end with a rare mix of policy clarity and policy risk—often at the same time. In the past 48 hours, the sector has been hit by major U.S. drug-pricing announcements, renewed focus on insurance premiums, and a fresh run of deal and IPO headlines that are reshaping investor expectations for 2026. Reuters+3Reuters+3Reuters+3

20 December 2025

NASDAQ:AMGN·NASDAQ:GILD·NYSE:BMY·NYSE:GSK·NYSE:MRK·NYSE:NVS·NYSE:SNY·Stock Market·SWX:ROG.SW

MSCI Europe vs World Indices: Performance, Forecasts and Key Drivers (5–7 December 2025)

LONDON, Dec. 7, 2025 — The MSCI Europe Index slipped modestly at the end of the week but remains one of 2025’s equity standouts, still ahead of broad global benchmarks such as the MSCI World and MSCI ACWI. European stocks are pausing after a powerful rally, even as fresh forecasts from major banks signal further upside into 2026 and technical indicators continue to lean constructive.

7 December 2025

EPA:LVMH·Financial Forecasts·LSE:HSBA·NASDAQ:ASML·NYSE:AZN·NYSE:SHEL·Stock Market·SWX:NESN.SW·SWX:NOVN.SW·SWX:ROG.SW·XETRA:SAP·XETRA:SIE

Swiss Stock Market Today, 26 November 2025: SMI Edges Higher as Sentiment Surges and Insurers Face Tougher Rules

The Swiss Market Index closed at 12,781.09 points, up 0.07% from Tuesday’s finish of 12,772.55. That’s the highest level in roughly a week and caps a three-session advance of about 1.0%, after gains of 0.94% on Tuesday and 0.17% on Monday.Investing.com+1

26 November 2025

Stock Market·SWX:EMMN.SW·SWX:NESN.SW·SWX:NOVN.SW·SWX:ROG.SW·SWX:SLHN.SW·SWX:SREN.SW·SWX:UBXN.SW·SWX:ZURN.SW

Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Olema Pharmaceuticals didn’t publish a press release or file anything with the SEC this morning. Yet, its stock rocketed nearly threefold in pre‑market trading on Tuesday, November 18, 2025. TipRanks+1

18 November 2025

Biotechnology·NASDAQ:OLMA·NYSE:PFE·Pharmaceuticals·Stock Market·SWX:ROG.SW

Swiss Stock Market Today, November 18, 2025: SMI Slips as Roche Soars, ABB, Zurich and ams-Osram Drag the Index

The Swiss Market Index traded lower on November 18, 2025, as global risk-off sentiment weighed on cyclicals and financials. Roche surged on breakthrough breast cancer data, while ABB, Zurich Insurance and ams-Osram fell after major investor updates and earnings news

18 November 2025

Stock Market·SWX:ABBN.SW·SWX:AMS.SW·SWX:ROG.SW·SWX:ZURN.SW

SWX:ROG.SW 18 November 2025 - 20 December 2025

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

MSCI Europe vs World Indices: Performance, Forecasts and Key Drivers (5–7 December 2025)

Swiss Stock Market Today, 26 November 2025: SMI Edges Higher as Sentiment Surges and Insurers Face Tougher Rules

Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Swiss Stock Market Today, November 18, 2025: SMI Slips as Roche Soars, ABB, Zurich and ams-Osram Drag the Index

TechStock² Updates

Twilio (NYSE:TWLO) shares surge 28% after quarterly Rule-of-40 proxy hits 41

Coherent Corp. (NYSE:COHR) jumps 41% over the week as China optics restrictions coincide with earnings report

Tesla Shares Rise, $16.8 Billion Terafab Project Puts Spotlight on Capital Plans

SK hynix loses 53 trillion won in market value, a sum close to its new fab investment

Cipher Digital (NASDAQ:CIFR) Shares Drop Amid Restricted Cash Issues Affecting Data-Center Appraisal

Top Stock Picks

Constellation Energy

AerCap

Walt Disney

AIG

Cheniere Energy

Live updates

Investment Disclaimer